Component
Acute inflammation
Inflammatory state that can change circulating selenium and protein distribution.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Pair-fed rats with adjuvant arthritis had lower plasma and liver PLP at peak/chronic inflammation, while muscle PLP and urinary 4-pyridoxic acid were not significantly changed.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- experimental_model
- Human cross-sectional comparison: 33 RA patients, 17 healthy controls; separate pair-fed rat adjuvant-arthritis experiment.
- exposure
- Human observational samples; rats studied at peak day 21 and chronic day 42 inflammation. Human arm shares recruitment program with supplementation study.
- limitations
- Separate rat model; neither universal muscle preservation nor directly measured human liver deficiency.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Rattus norvegicus
- plain_language
- In this animal experiment, inflammation changed some B6 pools more than others despite matched food supply.
- primary_references
- [b6-chiang2005-inflammation] Inflammation causes tissue-specific depletion of vitamin B6 (2005). https://pubmed.ncbi.nlm.nih.gov/16277678/ DOI: 10.1186/ar1821
- tissue_or_cell_type
- Rat liver, skeletal muscle, plasma and urine
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1535–1545
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human cross-sectional comparison: 33 RA patients, 17 healthy controls; separate pair-fed rat adjuvant-arthritis experiment. · source_derived_draft · unverified_draft
### b6-rat-inflammation-liver-muscle Pair-fed rats with adjuvant arthritis had lower plasma and liver PLP at peak/chronic inflammation, while muscle PLP and urinary 4-pyridoxic acid were not significantly changed. Condition category: biomarker_context nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: In this animal experiment, inflammation changed some B6 pools more than others despite matched food supply. organism: Rattus norvegicus tissue_or_cell_type: Rat liver, skeletal muscle, plasma and urine experimental_model: Human cross-sectional comparison: 33 RA patients, 17 healthy controls; separate pair-fed rat adjuvant-arthritis experiment. limitations: Separate rat model; neither universal muscle preservation nor directly measured human liver deficiency. exposure: Human observational samples; rats studied at peak day 21 and chronic day 42 inflammation. Human arm shares recruitment program with supplementation study. [b6-chiang2005-inflammation] Inflammation causes tissue-specific depletion of vitamin B6 (2005). https://pubmed.ncbi.nlm.nih.gov/16277678/ DOI: 10.1186/ar1821
Complete structured claim and evidenceAcute inflammation can lower circulating selenium through multiple illness-related processes.
Experimental context and source evidence
- availability_state
- Acute inflammation or severe illness changes hepatic priorities, protein distribution, losses, or intake.
- experimental_scope
- Inflammatory and acute-illness measurement context, including observational associations with illness severity.
- limitations
- Inflammation and true deficiency can coexist. This is neither proof of adequate nutrition nor proof that supplementation benefits outcomes. Deliberate nutritional immunity remains a hypothesis.
- trigger_kind
- biomarker_context
Selenium deficiency: a mechanism-first reference · lines 627–643
Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft
6.2 Acute-phase confounding Inflammation can lower circulating selenium and SELENOP. Cytokine signaling, hepatic reprioritization, albumin changes, redistribution, illness severity, renal losses, and nutritional intake can all contribute. acute inflammation / severe illness ↓ hepatic and systemic protein redistribution ↓ SELENOP and circulating selenium can fall Therefore: A low selenium concentration during acute illness does not, by itself, prove dietary deficiency. It also does not prove that nutritional deficiency is absent; inflammation and true deficiency can coexist. Associations between low selenium and poor ICU outcomes are vulnerable to reverse causation and confounding by illness severity.
Complete structured claim and evidenceAcute inflammation and associated hepatic or systemic changes can lower circulating SELENOP.
Experimental context and source evidence
- availability_state
- Acute inflammation or severe illness changes hepatic priorities, protein distribution, losses, or intake.
- experimental_scope
- Inflammatory and acute-illness measurement context, including observational associations with illness severity.
- limitations
- Inflammation and true deficiency can coexist. This is neither proof of adequate nutrition nor proof that supplementation benefits outcomes. Deliberate nutritional immunity remains a hypothesis.
- trigger_kind
- biomarker_context
Selenium deficiency: a mechanism-first reference · lines 629–635
Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft
Inflammation can lower circulating selenium and SELENOP. Cytokine signaling, hepatic reprioritization, albumin changes, redistribution, illness severity, renal losses, and nutritional intake can all contribute. acute inflammation / severe illness ↓ hepatic and systemic protein redistribution ↓ SELENOP and circulating selenium can fall
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.